NEW YORK (Reuters Health) – A long-term dietary intervention with grape resveratrol supplements improves the inflammatory and fibrinolytic status of patients at high risk of cardiovascular (CVD) disease,…
NEW YORK (Reuters Health) – On May 8, a panel of advisers to the US Food and Drug Administration unanimously voted against rilonacept (Arcalyst, Regeneron Pharmaceuticals) for use…
NEW YORK (Reuters Health) – Regardless of dosage, frequency or route of administration, vitamin D3 (cholecalciferol) is more efficacious in raising serum 25 hydroxyvitamin D concentrations than vitamin…
NEW YORK (Reuters Health) – Three years after a group of women with stress urinary incontinence were treated with transobturator tension-free vaginal tape (TO-TVT), roughly three-quarters felt the…
NEW YORK (Reuters Health) – The combination of estrogen and raloxifene seems to reduce menopausal symptoms and appears not to increase the risk of endometrial hyperplasia, researchers from…
NEW YORK (Reuters Health) – All-cause mortality rates among hypertensive patients treated with an angiotensin-converting enzyme inhibitor are 10% lower than in those whose treatment does not include…
NEW YORK (Reuters Health) – Based on the results of a randomized, double-blind trial, more adolescents with acute migraine become pain-free within 2 hours after taking a combination…
NEW YORK (Reuters Health) – In patients with aspirin-related peptic ulcers, ulcer healing rates are comparable after esomeprazole therapy with or without aspirin continuation, Taiwanese researchers report in…
NEW YORK (Reuters Health) – Both hand function and appearance are improved in rheumatoid arthritis (RA) patients with severe deformities treated by silicone metacarpophalangeal joint arthroplasty (SMPA), researchers…
NEW YORK (Reuters Health) – Skin prick testing results and early reactions are among indicators of the course of IgE-mediated cow’s milk allergy (CMA) in infants, Israeli researchers…
